Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Clene Inc. - Common Stock
(NQ:
CLNN
)
4.825
-0.165 (-3.31%)
Streaming Delayed Price
Updated: 10:58 AM EDT, Jul 29, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
68,842
Open
4.870
Bid (Size)
4.800 (400)
Ask (Size)
4.850 (100)
Prev. Close
4.990
Today's Range
4.785 - 5.040
52wk Range
3.250 - 13.50
Shares Outstanding
128,404,735
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Novel Multiple Sclerosis Therapy Toward Phase 2 Trials
June 22, 2026
Via
Investor Brand Network
Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis
June 22, 2026
From
BioMedWire
Via
GlobeNewswire
Performance
YTD
-16.4%
-16.4%
1 Month
-23.8%
-23.8%
3 Month
-17.5%
-17.5%
6 Month
-7.0%
-7.0%
1 Year
+41.9%
+41.9%
More News
Read More
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
November 14, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
October 31, 2025
Via
Benzinga
Landmark Study Shows How Menopause Influences the Symptoms of Multiple Sclerosis
September 26, 2025
Via
Investor Brand Network
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Presents Positive REPAIR-MS Results at ECTRIMS 2025
September 25, 2025
Via
Investor Brand Network
New Smart Pen Shows 96% Efficacy in Detecting Parkinson’s Disease
September 16, 2025
Via
Investor Brand Network
Clene Inc.’s (NASDAQ: CLNN) Lead Candidate CNM-Au8(R) Shows Promise in Improving Cellular Health in Parkinson’s Disease
September 16, 2025
Via
Investor Brand Network
MissionIRNewsBreaks – Clene Inc. (NASDAQ: CLNN) Advances Toward NDA Submission for ALS Therapy
September 09, 2025
Via
Investor Brand Network
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Presents Preclinical Data Showing CNM-Au8 Improves Cellular Health in Parkinson’s Disease Model
September 04, 2025
Via
Investor Brand Network
Research Uncovers Possible Way to Repair Myelin in MS Patients
September 04, 2025
Via
Investor Brand Network
BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Present at H.C. Wainwright Global Investment Conference
September 02, 2025
Via
Investor Brand Network
InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) Builds Late-Stage Momentum in Neuro Pipeline
August 29, 2025
Via
Investor Brand Network
Pioneering Therapy Could Slow the Effects of Aging
August 22, 2025
Via
Investor Brand Network
Clene Inc. (NASDAQ: CLNN) Reports Q2 2025 Results as Company Prepares for NDA Submission and Extends Runway into 2026
August 21, 2025
Via
Investor Brand Network
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
August 20, 2025
Via
Benzinga
BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) Reports Q2 2025 Results, Targets Year-End NDA Submission for ALS Therapy
August 14, 2025
Via
Investor Brand Network
Clene Posts 70% Revenue Drop in Q2
↗
August 14, 2025
Via
The Motley Fool
InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Present Corporate Update at Emerging Growth Conference on Aug. 20
August 13, 2025
Via
Investor Brand Network
Parkinson’s-Gut Bacteria Link Suggests Surprisingly Simple Treatment Option
August 12, 2025
Via
Investor Brand Network
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) to Present at Canaccord 45th Annual Growth Conference
August 05, 2025
Via
Investor Brand Network
New AI-Based Speech Tool Detects Possibility of Parkinson’s Disease
July 31, 2025
Via
Investor Brand Network
Clene Inc. (NASDAQ: CLNN) Offers Investors a Compelling Entry into the Growing ALS Market with Key FDA Milestones for Lead Drug Candidate
July 28, 2025
Via
Investor Brand Network
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Builds Momentum to Bring New Hope to Neuro Patients
July 25, 2025
Via
Investor Brand Network
12 Health Care Stocks Moving In Friday's After-Market Session
↗
July 18, 2025
Via
Benzinga
Frequently Asked Questions
Is Clene Inc. - Common Stock publicly traded?
Yes, Clene Inc. - Common Stock is publicly traded.
What exchange does Clene Inc. - Common Stock trade on?
Clene Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Clene Inc. - Common Stock?
The ticker symbol for Clene Inc. - Common Stock is CLNN on the Nasdaq Stock Market
What is the current price of Clene Inc. - Common Stock?
The current price of Clene Inc. - Common Stock is 4.825
When was Clene Inc. - Common Stock last traded?
The last trade of Clene Inc. - Common Stock was at 07/29/26 10:58 AM ET
What is the market capitalization of Clene Inc. - Common Stock?
The market capitalization of Clene Inc. - Common Stock is 619.55M
How many shares of Clene Inc. - Common Stock are outstanding?
Clene Inc. - Common Stock has 620M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
